Search Results for keywords:"vaccine adjuvant development"

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on February 3-4, 2024, to review contract proposals related to vaccine adjuvant development. This meeting is closed to the public to protect sensitive information like trade secrets and personal privacy. The meeting will take place via video at the NIH facility in Rockville, MD. For further details, Michael M. Opata, Ph.D., is the contact person.

The National Institute of Allergy and Infectious Diseases (NIAID) is holding a closed meeting to review and evaluate contract proposals. This meeting will involve discussions about confidential trade secrets and personal information, which is why it’s not open to the public. The meeting is scheduled for April 3-4, 2025, from 9:00 a.m. to 6:00 p.m., and will be conducted via video assistance at the NIAID location in Rockville, Maryland. The meeting addresses a solicitation focused on vaccine adjuvant development as part of the Small Business Innovation Research (SBIR) program.